iShares 7-10 Year Treasury Bond ETF vs Philip Morris International Inc. — how do they compare? iShares 7-10 Year Treasury Bond ETF trades at $93.37, while Philip Morris International Inc. trades at $191.48 (market cap $300.37B). The key difference: Philip Morris International Inc. pays a 3.05% dividend while iShares 7-10 Year Treasury Bond ETF pays none, and Philip Morris International Inc. is trading nearer its 52-week high, iShares 7-10 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| IEF | PM | |
|---|---|---|
52-Week High | $97.99 | $192.98 |
52-Week Low | $93.11 | $144.33 |
Market Cap | — | $300.37B |
Sector | — | Consumer Staples |
Enterprise Value | — | $346.86B |
Dividend Yield | — | 3.05% |
Signals from Pluang's Aura AI — not financial advice
IEF (iShares 7-10 Year Treasury Bond ETF) trades at $93.54, down 0.32% with a bearish technical signal from moving averages. The ETF shows neutral oscillator readings with RSI at 58.33, while bond market uncertainty persists amid Federal Reserve policy speculation. Recent dividend payments of $0.31-$0.32 reflect steady income distribution to shareholders.
The outlook remains cautious as bond ETFs face pressure from potential rate hikes and inflation concerns. Investment opportunity lies in Treasury exposure for portfolio diversification, though risks include interest rate sensitivity and macroeconomic volatility affecting bond valuations.
No Aura AI signal available yet.
Trailing returns across standard periods
The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity of greater than or equal to seven years and less than ten years. The fund will invest at least 80% of its assets in the component securities of the underlying index, and the fund will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index.
Read more on IEF →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →